This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Brandenburgische Technische Universität Cottbus-Senftenberg, Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts, Ga Generic Assays Gmbh. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2022
Title: Cläre Von Neubeck: Innovator in Biomarker Evaluation
Introduction
Cläre Von Neubeck is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of biomedical engineering, particularly in the evaluation of biomarkers in tissue samples. His innovative approach combines advanced imaging techniques with computer-assisted analysis.
Latest Patents
Cläre Von Neubeck holds a patent for a method, system, and computer program designed for the computer-assisted evaluation of biomarkers in a tissue sample. This patent outlines a comprehensive method that includes providing an image of the tissue sample, determining blood vessel probabilities, identifying assumed blood vessel locations, selecting biomarkers, and evaluating these biomarkers automatically. This invention represents a significant advancement in the analysis of tissue samples, enhancing the accuracy and efficiency of biomarker evaluation.
Career Highlights
Throughout his career, Cläre has worked with prestigious institutions such as the Deutsches Krebsforschungszentrum (German Cancer Research Center) and Brandenburgische Technische Universität Cottbus-Senftenberg. His work in these organizations has allowed him to develop and refine his innovative methods for biomarker evaluation.
Collaborations
Cläre has collaborated with notable colleagues, including Rico Hiemann and Alexey Elimport. These partnerships have contributed to the development and success of his patented technologies.
Conclusion
Cläre Von Neubeck's contributions to the field of biomarker evaluation through his innovative patent demonstrate his commitment to advancing medical research and technology. His work continues to influence the way tissue samples are analyzed, paving the way for future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile